CHRISTOPH GAUL,MARK GARY BOCK,SAUMITRA SENGUPTA,VENKATESHWAR RAO GUMMADI
申请号：
BR112013027395
公开号：
BR112013027395A2
申请日:
2012.04.27
申请国别(地区):
BR
年份:
2017
代理人:
摘要：
abstract the present invention provides compounds of formula (i), or a pharmaceutically acceptable salt thereof, (i) where r1, r2, r3, r4, r5 and r6 are as defined herein. the compounds of the present invention have been found to be useful as 17? -hydroxylase / c17,20-lyase inhibitors. ******************************** Summary of the Summary Patent Summary: "17? -hydroxylase / c17 inhibitors, 20-lyase ". The present invention provides compounds of formula (I) or a pharmaceutically acceptable salt thereof, (i) wherein r1, r2, r3, r4, r5 and r6 are as defined herein. The compounds of the present invention have been found to be useful as 17'-hydroxylase / c17,20-lyase inhibitors. 1/1abstract the present invention provides compounds of formula (i), or a pharmaceutically acceptable salt thereof, (i) where r1, r2, r3, r4, r5 and r6 are as defined herein. the compounds of the present invention have been found to be useful as 17?-hydroxylase/c17,20-lyase inhibitors. ******************************** tradução do resumo resumo patente de invenção: "inibidores de 17?-hidroxilase/c17,20-liase". a presente invenção fornece compostos de fórmula (i) ou um sal farmaceuticamente aceitável dos mesmos, (i) em que r1, r2, r3, r4, r5 e r6 são como aqui definidos. foi descoberto que os compostos da presente invenção são úteis como inibidores de 17?-hidroxilase/c17,20-liase. 1/1
